VIVIMEDLAB.NSVIVIMEDLAB.NSNSE
Loading
EBITDA Over TimeContracting
Percentile Rank27
5Y CAGR-41.9%
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

5Y CAGR
-41.9%/yr
Long-term compound
Percentile
P27
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
3 yr
Consecutive growthContracting
PeriodValueYoY Change
TTM$22.30M+125.7%
2025$-86.77M+64.8%
2024$-246.69M+86.7%
2023$-1.86B-2637.9%
2022$-67.91M-120.2%
2021$336.05M+105.3%
2020$163.69M-91.3%
2019$1.89B-16.5%
2018$2.27B-46.2%
2017$4.21B-